Michael S. Gilmore, Ph.D.
Sir William Osler Professor of Ophthalmology
Department of Ophthalmology
Member, Biological and Biomedical Sciences Program
Harvard Medical School
Member, Microbial Sciences Initiative
My laboratory focuses on developing new ways to treat and prevent antibiotic resistant infection of the eye, ear, skin and other sites caused by enterococci and staphylococci. Enterococci and staphylococci are leading causes of multidrug resistant infection, particularly in hospitalized patients. Since 2005, more people in the US have been killed by methicillin-resistant Staphylococcus aureus infection than by HIV/AIDS, and antibiotic resistant infection is adding more than $ 30 Billion per year to health care costs. To read more about Dr. Gilmore's research, please click here.
M.S., Ph.D.. 1982, University of Oklahoma Health Sciences Center, Biochemistry and Molecular Biology